Netherlands· NL-dea7d55998a1
Ammonaps 500 mg tabletten
A sodium phenylbutyrate product containing natriumfenylbutyraat, registered in Netherlands by Immedica Pharma AB. The same ATC class is registered in 14 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Sodium phenylbutyrate is registered in 14 of 19 countries.
Countries holding a registration under ATC A16AX03 (sodium phenylbutyrate), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Sodium phenylbutyrate · ATC A16AX03
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of sodium phenylbutyrate costs, country by country.
Normalised to the WHO defined daily dose (20 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sodium phenylbutyrate · price per daily dose (20 g)
USD · FX 28 Sept 2026
- CZ Czechia$0.46
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- NATRIUMFENYLBUTYRAAT
- Manufacturer
- Immedica Pharma AB
- Country
- Netherlands (NL)
- ATC code
- A16AX03
- ATC class
- Sodium phenylbutyrate
- Defined daily dose
- 20 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/99/120
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sodium phenylbutyrate in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainAMMONAPS 500 MG COMPRIMIDOSImmedica Pharma Ab
- IcelandAmmonapsImmedica Pharma AB
- PolandAmmonapsImmedica Pharma AB
- FrancePHEBURANE 350 mg/mL, solution buvableEUROCEPT INTERNATIONAL (PAYS-BAS)
- Japanフェニル酪酸ナトリウムオーファンパシフィック
- SwitzerlandPheburane 483 mg/g, Granulat zur Herstellung einer Lösung zum EinnehmenMedius AG
- ItalyPHEBURANE*orale grat sosp 174 g 483 mg/gEUROCEPT INTERNATIONAL B.V.
- CzechiaPHEBURANEEurocept International BV, Ankeveen
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6e042f9d-9a18-457b-9bf8-d8d4a004ef70 GET /v1/drugs/6e042f9d-9a18-457b-9bf8-d8d4a004ef70?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/ammonaps-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Sodium Phenylbutyrate",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp70414",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"MAGNESIUMSTEARAAT (E 470b)",
"SILICIUMDIOXIDE (E 551)"
],
"substances": [
"NATRIUMFENYLBUTYRAAT"
],
"leaflet_url": null,
"authorised_at": "1999/12/08",
"procedure_number": "EMEA/H/C/000219",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/99/120",
"additional_monitoring": "N"
}See everything about sodium phenylbutyrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.